Association between non-steroidal anti-inflammatory drugs and keratinocyte carcinomas of the skin among participants in the Veterans Affairs Topical Tretinoin Chemoprevention Trial

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 9, 2011, Pages 922-929

  Nunes, Anthony P ^a   Lapane, Kate L ^b   Weinstock, Martin A ^a,c,d,e  

^a BROWN UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

Basal cell carcinoma; Keratinocyte carcinoma; Non steroidal anti inflammatory drugs (NSAID); Squamous cell carcinoma

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; RETINOIC ACID;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CHEMOPROPHYLAXIS; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; FOLLOW UP; HUMAN; KERATINOCYTE; MAJOR CLINICAL STUDY; PARTICIPANT OBSERVATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; VETERAN;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARCINOMA; COHORT STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; SKIN NEOPLASMS; TRETINOIN; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 80052361677     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2142     Document Type: Article

References (25)

1. Asgari M, White E, Chren MM. Nonsteroidal anti-inflammatory drug use in the prevention and treatment of squamous cell carcinoma. Dermatol Surg 2004; 30: 1335-1342.
2. Butler GJ, Neale R, Green AC, Pandeya N, Whiteman DC. Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin. J Am Acad Dermatol 2005; 53: 966-972.
3. Clouser MC, Roe DJ, Foote JA, Harris RB. Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial. Pharmacoepidemiol Drug Saf 2009; 18: 276-283.
4. Grau MV, Baron JA, Langholz B, et al. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer. Int J Cancer 2006; 119: 682-686.
5. Sorensen HT, Friis S, Norgard B, et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 2003; 88: 1687-1692.
6. Vogel U, Christensen J, Wallin H, Friis S, Nexø BA, Tjønneland A. Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes. Mutat Res 2007; 617: 138-146.
7. Vogt T, McClelland M, Jung B, et al. Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II. Melanoma Res 2001; 11: 587-599.
8. Beyersmann J, Gastmeier P, Wolkewitz M, Schumacher M. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol 2008; 61: 1216-1221.
9. van Walraven C, Davis D, Forster AJ, Wells GA. Time-dependent bias was common in survival analyses published in leading clinical journals. J Clin Epidemiol 2004; 57: 672-682.
10. Suissa S. Immortal time bias in pharmacoepidemiology. Am J Epidemiol 2009; 167: 492-499.
11. Weinstock MA, Bingham SF, Lew RA, et al. Topical tretinoin therapy and all-cause mortality. Arch Dermatol 2009; 145: 18-24.
12. Jagdeo J, Weinstock MA, Piepkorn M, Bingham SF; Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group. Reliability of the histopathologic diagnosis of keratinocyte carcinomas. J Am Acad Dermatol 2007; 57: 279-284.
13. Weinstock MA, Bingham SF, Cole GW, et al. Reliability of counting actinic keratoses before and after brief consensus discussion: the VA topical tretinoin chemoprevention (VATTC) trial. Arch Dermatol 2001; 137: 1055-1058.
14. Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA; VATTC Trial Group. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC Trial. J Natl Cancer Inst 2008; 100: 1223-1232.
15. Weinstock MA, Lee KC, Chren MM, Marcolivio K; VATTC Trial Group. Quality of life in the actinic neoplasia syndrome: the VA Topical Tretinoin Chemoprevention (VATTC) Trial. J Am Acad Dermatol 2009; 61: 207-215.
16. Buckman SY, Gresham A, Hale P, et al. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998; 19: 723-729.
17. Fosslien E. Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci 2000; 30: 3-21.
18. Muller-Decker K, Reinerth G, Krieg P, et al. Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin. Int J Cancer 1999; 82: 648-656.
19. Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998; 104: 413-421.
20. Weinstock MA. Assessment of sun sensitivity by questionnaire: validity of items and formulation of a prediction rule. J Clin Epidemiol 1992; 45: 547-552.
21. Dore DD, Lapane KL, Trivedi AN, Mor V, Weinstock MA. Association between statin use and risk for keratinocyte carcinoma in the veterans affairs topical tretinoin chemoprevention trial. Ann Intern Med 2009; 150: 9-18.
22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
23. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993; 46: 1075-9; discussion 81-90.
24. Elmets CA, Viner JL, Pentland AP, et al. The cyclooxygenase-2 inhibitor celecoxib effectively suppresses the development of non melanoma skin cancers: results of a phase II/III clinical trial. Presented at the 69th Annual Meeting of the Society for Investigative Dermatology, Quebec, Canada, 6-9 May 2009.
25. Beyersmann J, Wolkewitz M, Schumacher M. The impact of time-dependent bias in proportional hazards modelling. Stat Med 2008; 27: 6439-6454.